Can a Dermoid Cyst Be Cancerous? What You Should Know

Dermoid cysts are almost always benign. Malignant transformation happens in roughly 1 to 2 percent of cases, most often in ovarian dermoid cysts that are unusually large or found in women over 40. That low percentage matters because dermoid cysts are among the most common ovarian tumors in reproductive-age women, so even a small rate of cancerous change affects a meaningful number of people over time. The biology behind that rare shift, who it affects, and how doctors catch it are worth understanding if you or someone you know has been diagnosed with one.

What a Dermoid Cyst Actually Is

A dermoid cyst, known in medical terminology as a mature cystic teratoma, is a type of germ cell tumor. It forms from cells that have the ability to develop into many different tissue types, which is why opening one up during surgery can reveal a bizarre mix of hair, skin, teeth, fat, and even fragments of bone or thyroid tissue. The cyst wall and its contents come from all three embryonic tissue layers, and the greasy, sebaceous material inside is the most common finding.1PubMed Central. Mature Cystic Teratoma: An Integrated Review These cysts are considered congenital, meaning the cells that eventually form them are present from birth, even if the cyst does not become noticeable until years or decades later.

Dermoid cysts most commonly show up in the ovaries, but they can also appear in the head, neck, and other locations throughout the body.2Journal of Pediatric Surgery Case Reports. Pediatric paraduodenal dermoid cyst: Clinical presentation, minimally invasive management and literature review Wherever they grow, the overwhelming majority are benign, slow-growing masses. Most people with a dermoid cyst will never experience a cancerous change. But “almost never” is not “never,” and the distinction between the two is where the clinical concern lies.

The 1 to 2 Percent That Turn Malignant

When researchers talk about dermoid cysts becoming cancerous, they are describing a process called malignant transformation, where cells within the otherwise benign cyst begin to grow in an uncontrolled, invasive way. This happens in about 1 to 2 percent of ovarian dermoid cysts.3PubMed. Squamous cell carcinoma arising in a dermoid cyst of the ovary: a case series The most common cancer that arises is squamous cell carcinoma, a type of skin cancer that develops from the skin-like lining inside the cyst.4PubMed Central. Malignancy Arising in Dermoid Cysts: A Case Report and Literature Review Because dermoid cysts contain so many different tissue types, however, other cancers can emerge too. Case reports have documented melanoma, transitional cell carcinoma, and even sarcoma arising within dermoid cysts.5PubMed Central. Squamous cell carcinoma and osteosarcoma arising from a dermoid cyst–a case report and review of literature When the cyst contains a large amount of thyroid tissue (a variant called struma ovarii), papillary thyroid carcinoma can develop within the ovary itself.6PubMed Central. Struma ovarii with papillary thyroid carcinoma

This variety is part of what makes malignant dermoid cysts tricky. The cancer type depends on which tissue inside the cyst transforms, and squamous cell carcinoma behaves differently from thyroid carcinoma, which behaves differently from sarcoma. Treatment has to be tailored to whichever malignant cell type has taken hold.7PubMed. Mature cystic teratoma and their malignant transformation

Who Faces Higher Risk

Two factors stand out in the research on malignant transformation: age and cyst size. Malignant change in ovarian dermoid cysts occurs most often in women over 40, and the risk is especially concentrated in cysts larger than about 18 centimeters in diameter.4PubMed Central. Malignancy Arising in Dermoid Cysts: A Case Report and Literature Review For perspective, most dermoid cysts discovered incidentally on imaging are well under 10 centimeters. A cyst that has grown to 18 centimeters or beyond is already unusual and would almost certainly have prompted medical attention on its own.

Young women with small, uncomplicated dermoid cysts carry an extremely low risk of malignancy. That does not mean the cysts should be ignored entirely, since they can still cause problems like ovarian torsion (twisting of the ovary) or rupture, but the cancer concern specifically is far more relevant to older patients with large-growing masses. Case series studying malignant transformation have reinforced this pattern, finding that the typical patient is middle-aged and the cyst has been present, often undetected, for years.8PubMed Central. Are Ovarian Dermoid Cysts Should Be Always Considered Benign? A Case Series Study of Different Malignant Transformation

Mature Versus Immature Teratomas

An important distinction that often causes confusion is the difference between a mature teratoma (the standard dermoid cyst) and an immature teratoma. Both are germ cell tumors, and both can contain a mix of tissue types. But they are fundamentally different in behavior. Mature teratomas are benign by definition, with malignant transformation being that rare 1 to 2 percent exception. Immature teratomas, on the other hand, are malignant from the start. They contain embryonic-looking tissue that has not fully developed, most often immature neural (brain-like) tissue, and they are treated as ovarian cancers from the moment of diagnosis.9PubMed. Teratoma of the ovary. Clinical and pathological differences between mature and immature teratomas

If your pathology report says “mature cystic teratoma” or “dermoid cyst,” the tumor itself was benign. The pathologist will specifically look for signs that any component has undergone malignant change, and if nothing abnormal is found, the prognosis is excellent. Immature teratomas are far less common and tend to occur in younger patients, usually in their teens and twenties, whereas mature dermoid cysts peak in the reproductive years but can be found at any age.

How Doctors Spot Trouble on Imaging

Most dermoid cysts are diagnosed through ultrasound, where they have a fairly recognizable appearance: a complex cyst with echogenic (bright) areas that correspond to fat, hair, and calcified structures like teeth. That characteristic look is usually enough for a confident diagnosis. The trickier question is whether a dermoid cyst has undergone malignant transformation, and unfortunately, standard ultrasound is not great at catching this.

MRI provides more detailed information. In a study of malignant dermoid cysts, the cancerous lesions appeared as fat-containing tumors with a solid component that extended through the cyst wall and, in several cases, invaded surrounding pelvic structures. The pattern of spread was different from typical ovarian cancers, involving direct local invasion rather than widespread seeding throughout the abdomen.10PubMed. Dermoid cysts of the ovary with malignant transformation: MR appearance If your doctor orders an MRI after an ultrasound shows a dermoid cyst, it may be because something about the cyst’s appearance warrants a closer look, particularly a prominent solid area or irregular wall thickening.

Blood tests can add another piece to the puzzle but are not definitive on their own. The tumor marker CA 19-9 tends to be elevated in women with ovarian dermoid cysts, and research suggests it tracks with cyst size: as the cyst gets bigger, CA 19-9 levels tend to rise.11PubMed. Tumor markers panel and tumor size of ovarian dermoid tumors in reproductive age An elevated CA 19-9 level does not mean cancer is present. It simply reflects the cyst itself. More conventional cancer markers like CA-125, which are elevated in many epithelial ovarian cancers, are not reliable indicators for dermoid-related malignancies. None of these markers can definitively distinguish a benign dermoid from one undergoing malignant transformation; that determination ultimately requires pathology examination of the removed tissue.

Dermoid Cysts Outside the Ovary

While the cancer discussion centers on ovarian dermoid cysts, dermoid cysts elsewhere in the body behave differently and carry even less malignant potential. Scalp dermoid cysts, for instance, are among the most common congenital lumps in children. Because they consist of fully mature tissues, they are benign, and management typically involves straightforward surgical removal.12Springer. Scalp dermoids: a review of their anatomy, diagnosis, and treatment The main concern with scalp dermoids is not cancer but rather whether the cyst has any connection to the underlying skull bone or the brain covering beneath it, which affects the surgical approach.

Orbital and periorbital dermoid cysts, found around the eye, are another common presentation. In adults, these cysts can erode into bone over time, creating bony defects that make surgery more complex. A comparison of children and adults with orbital dermoid cysts found that adults were significantly more likely to have vision changes, limited eye movement, and bony erosion, as well as a higher rate of the cyst rupturing during surgery and more inflammation on tissue examination.13PubMed. Orbital and periorbital dermoid cysts: Comparison of clinical features and management outcomes in children and adults Even so, the concern with orbital dermoids is local damage and surgical complexity, not malignancy.

A related but distinct entity is the intracranial epidermoid cyst, which shares some features with dermoids but is not exactly the same. Malignant transformation in these is exceedingly rare, though case reports exist of cancerous change developing decades after incomplete surgical removal.14Neurologia medico-chirurgica. Malignant Transformation 20 Years After Partial Removal of Intracranial Epidermoid Cyst These cases are so uncommon that they make the literature as individual case reports, which is itself a measure of how rare they are.

Surgery, Spillage, and What to Expect

The standard treatment for a symptomatic or growing dermoid cyst is surgical removal. For ovarian dermoids, surgeons generally aim to remove just the cyst while preserving the ovary (a procedure called cystectomy), particularly in younger women who may want to have children. When malignant transformation is discovered, the approach changes entirely and may involve removal of the uterus, both ovaries, and surrounding tissue, followed by chemotherapy.15PubMed Central. Malignancy Arising in Dermoid Cysts: A Case Report and Literature Review – Section: Discussion

One complication unique to dermoid cyst surgery is spillage. Because these cysts are filled with oily, hair-laden material, rupture during the procedure can release contents into the abdominal cavity. This can trigger chemical peritonitis, an inflammatory reaction to the spilled material that causes abdominal pain and, in some cases, adhesion formation. A systematic review found that dermoid cyst rupture during surgery was significantly associated with chemical peritonitis.16PubMed. Short- and Long-Term Complications of Intraoperative Benign Ovarian Cyst Spillage: A Systematic Review and Meta-analysis One study found that about 8 percent of women who experienced spillage during surgery developed granulomatous peritonitis, and the authors recommended routine use of retrieval bags during laparoscopic removal to contain the cyst contents.17PubMed. Does prevention of intraperitoneal spillage when removing a dermoid cyst prevent granulomatous peritonitis?

If your surgeon discusses the possibility of spillage before your procedure, this is what they are referring to. It is an annoying complication, not a dangerous one in most cases, but surgeons take steps to minimize it.

Treatment When Cancer Is Found

Discovering malignancy in what was expected to be a routine dermoid cyst removal is almost always a surprise. In many cases, the cancer is only identified when the pathologist examines the tissue after surgery. If the initial operation was a simple cystectomy and malignancy is found on pathology, a second, more extensive surgery may be needed.

There is no universally agreed-upon chemotherapy regimen for malignant dermoid cysts, in part because cases are so rare that large randomized trials do not exist. Research suggests that platinum-based chemotherapy is the most commonly used approach, and studies have found that patients who completed a full course of treatment had notably better outcomes. In one case series, all patients who finished six to eight cycles of platinum-based chemotherapy achieved complete remission, while the two patients who stopped treatment early due to disease progression ultimately died of their disease. The estimated five-year survival rate in that series was around 31 percent, which reflects the fact that many cases are caught at advanced stages.18PubMed Central. Malignant transformation arising from mature ovarian cystic teratoma: A case series That figure can be misleading in isolation; patients diagnosed at an early stage fare considerably better than those with advanced disease.

For younger women with early-stage disease, fertility-sparing surgery has been performed with good outcomes, allowing the preservation of one ovary and the uterus.19International Journal of Gynecological Cancer. Malignant Transformation Within Ovarian Dermoid Cysts: An Audit of Treatment Received and Patient Outcomes This is only an option when the cancer is confined to one ovary and has not spread, and it requires close long-term surveillance afterward.

Recurrence After Removal of a Benign Dermoid Cyst

Even when a dermoid cyst is entirely benign, there is a chance of recurrence, particularly when the surgeon performs a cystectomy (removing just the cyst) rather than removing the entire ovary. A study of young women found five-year recurrence rates of about 11 percent after cystectomy and about 20 percent after oophorectomy (removal of the whole ovary), though the comparison is complicated by the fact that patients who needed an oophorectomy often had more complex or bilateral disease to begin with. Larger cyst size and cysts affecting both ovaries were significant predictors of recurrence in the cystectomy group.20PubMed. Five-year recurrence pattern of mature cystic teratoma according to operation type in young women

The surgical approach also matters. Research comparing laparoscopic surgery (keyhole surgery) with open surgery (laparotomy) found that the probability of recurrence at two years was about 7.6 percent in the laparoscopy group and zero in the laparotomy group, though the laparoscopy group also had a higher reintervention rate.21PubMed. Short-term morbidity and long-term recurrence rate of ovarian dermoid cysts treated by laparoscopy versus laparotomy Laparoscopy still carries significant advantages in terms of recovery time and postoperative pain, which is why it remains the preferred approach for most benign dermoid cysts. The trade-off is a slightly higher chance of needing a follow-up procedure down the line. Your doctor will likely recommend periodic ultrasounds for a few years after surgery to watch for regrowth.

Dermoid Cysts Discovered During Pregnancy

Dermoid cysts are the single most common type of adnexal mass that requires surgical management during pregnancy, accounting for about a third of such cases.22American Journal of Obstetrics and Gynecology. Adnexal masses during pregnancy: diagnosis, treatment, and prognosis Many are found incidentally on early pregnancy ultrasounds. The good news is that roughly 70 percent of adnexal masses discovered during pregnancy resolve on their own, and only about 2 percent turn out to be malignant.

For the cysts that do not resolve, the decision about whether and when to operate involves balancing the risk of torsion (the ovary twisting on itself, cutting off blood supply) against the risks of surgery during pregnancy. The second trimester is generally considered the safest window for surgery if it becomes necessary, giving time for possible spontaneous resolution while the uterus is still small enough to allow good surgical access. A dermoid cyst discovered during pregnancy that is small, stable, and not causing symptoms will usually be monitored rather than operated on, with definitive treatment deferred until after delivery.

The malignancy rate for adnexal masses in pregnancy is low across all types, and there is no evidence that pregnancy itself increases the risk of malignant transformation in a dermoid cyst. The primary concern during pregnancy is mechanical: a growing uterus can shift the cyst’s position, and the combination of an enlarging uterus and a sizeable cyst can increase the risk of torsion, which is a surgical emergency regardless of whether you are pregnant.